Treatment with the pan-sirtuin inhibitor nicotinamide induced Pax5 degradation in HAFTL cells and B-ALL KOPN-8 cells, whereas the expression of Pax5 mRNA was unaffected (Fig. 3j and Extended Data Fig. 5f,g). The gene discussed is PAX5; the disease is acute lymphoblastic leukemia.